These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 16798220)

  • 21. Which is the Role of Pneumonectomy in the Era of Parenchymal-Sparing Procedures? Early/Long-Term Survival and Functional Results of a Single-Center Experience.
    Janet-Vendroux A; Loi M; Bobbio A; Lococo F; Lupo A; Ledinot P; Magdeleinat P; Roche N; Damotte D; Regnard JF; Alifano M
    Lung; 2015 Dec; 193(6):965-73. PubMed ID: 26411589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.
    Dimopoulou I; Galani H; Dafni U; Samakovii A; Roussos C; Dimopoulos MA
    Cancer; 2002 Jan; 94(2):452-8. PubMed ID: 11900231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative serum fibrinogen level predicts postoperative pulmonary complications after lung cancer resection.
    Song SW; Lee HS; Kim MS; Lee JM; Kim JH; Nam BH; Zo JI
    Ann Thorac Surg; 2006 Jun; 81(6):1974-81. PubMed ID: 16731116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbon monoxide lung diffusion capacity improves risk stratification in patients without airflow limitation: evidence for systematic measurement before lung resection.
    Brunelli A; Refai MA; Salati M; Sabbatini A; Morgan-Hughes NJ; Rocco G
    Eur J Cardiothorac Surg; 2006 Apr; 29(4):567-70. PubMed ID: 16481190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of lung resection on exercise capacity and on carbon monoxide diffusing capacity during exercise.
    Wang JS; Abboud RT; Wang LM
    Chest; 2006 Apr; 129(4):863-72. PubMed ID: 16608931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lung scintigraphy and ergospirometry in prediction of postoperative course in lung resection candidates with increased risk of postoperative complications].
    Bolliger CT; Wyser C; Roser H; Stulz P; Solèr M; Perruchoud AP
    Pneumologie; 1996 May; 50(5):334-41. PubMed ID: 8710817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of and risk factors for postoperative pulmonary complications after lung cancer surgery in patients with early-stage COPD.
    Kim ES; Kim YT; Kang CH; Park IK; Bae W; Choi SM; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Kim YW; Han SK; Yoo CG
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1317-26. PubMed ID: 27366059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lung toxicity of trimodality chemoradiotherapy with mitomycin C, vindesine, and cisplatin followed by surgery for locally advanced non-small cell lung cancer].
    Sawa T; Yoshida T; Ishiguro T; Ogawara M; Kawahara M; Yamamoto S; Yokota S; Maeda H; Asamoto H
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1745-9. PubMed ID: 14619509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative pulmonary function as a predictor of respiratory complications and mortality in patients undergoing lung cancer resection.
    Fujiu K; Kanno R; Suzuki H; Shio Y; Higuchi M; Ohsugi J; Oishi A; Gotoh M
    Fukushima J Med Sci; 2003 Dec; 49(2):117-27. PubMed ID: 15065638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.
    Stathopoulos GP; Dafni UG; Malamos NA; Rigatos S; Kouvatseas G; Moschopoulos N
    Anticancer Res; 1999; 19(4C):3543-8. PubMed ID: 10629650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative complications of pulmonary resection after platinum-based induction chemotherapy for primary lung cancer.
    Muraoka M; Oka T; Akamine S; Tagawa T; Nagayasu T; Tagawa Y; Ayabe H
    Surg Today; 2003; 33(1):1-6. PubMed ID: 12560899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicted versus observed FEV1 and DLCO after major lung resection: a prospective evaluation at different postoperative periods.
    Brunelli A; Refai M; Salati M; Xiumé F; Sabbatini A
    Ann Thorac Surg; 2007 Mar; 83(3):1134-9. PubMed ID: 17307474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chest wall resection for non-small cell lung cancer: A case-matched study of postoperative pulmonary function and quality of life.
    Liu M; Wampfler JA; Dai J; Gupta R; Xue Z; Stoddard SM; Cassivi SD; Jiang G; Yang P
    Lung Cancer; 2017 Apr; 106():37-41. PubMed ID: 28285692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minute ventilation-to-carbon dioxide output (VE/VCO2) slope is the strongest predictor of respiratory complications and death after pulmonary resection.
    Brunelli A; Belardinelli R; Pompili C; Xiumé F; Refai M; Salati M; Sabbatini A
    Ann Thorac Surg; 2012 Jun; 93(6):1802-6. PubMed ID: 22560968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The National Surgical Quality Improvement Program risk calculator does not adequately stratify risk for patients with clinical stage I non-small cell lung cancer.
    Samson P; Robinson CG; Bradley J; Lee A; Broderick S; Kreisel D; Krupnick AS; Patterson GA; Puri V; Meyers BF; Crabtree T
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):697-705.e1. PubMed ID: 26410001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer.
    Taylor MD; LaPar DJ; Isbell JM; Kozower BD; Lau CL; Jones DR
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):738-44; Discussion 744-6. PubMed ID: 24252944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thoracoscopic lobectomy is associated with acceptable morbidity and mortality in patients with predicted postoperative forced expiratory volume in 1 second or diffusing capacity for carbon monoxide less than 40% of normal.
    Burt BM; Kosinski AS; Shrager JB; Onaitis MW; Weigel T
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):19-28, dicussion 28-29.e1. PubMed ID: 24766848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction chemotherapy for T4 centrally located non-small cell lung cancer.
    Rendina EA; Venuta F; De Giacomo T; Ciccone AM; Ruvolo G; Coloni GF; Ricci C
    J Thorac Cardiovasc Surg; 1999 Feb; 117(2):225-33. PubMed ID: 9918961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary function tests as a predictor of quantitative and qualitative outcomes after thoracic surgery for lung cancer.
    Greillier L; Thomas P; Loundou A; Doddoli C; Badier M; Auquier P; Barlési F
    Clin Lung Cancer; 2007 Nov; 8(9):554-61. PubMed ID: 18186960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early and long-term validation of an algorithm assessing fitness for surgery in patients with postoperative FEV₁ and diffusing capacity of the lung for carbon monoxide < 40%.
    Puente-Maestú L; Villar F; González-Casurrán G; Moreno N; Martínez Y; Simón C; Peñalver R; González-Aragoneses F
    Chest; 2011 Jun; 139(6):1430-1438. PubMed ID: 20930005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.